【Invitation】 September 22nd "Tang Prize Masters' Forums-Biopharmaceutical Science"
To take on the challenges unique to the 21st century and to ensure the sustainable development of mankind and nature, Dr. Samuel Yin established the Tang Prize in 2012 to recognize individuals or organizations for their great contributions to the fields of sustainable development, biopharmaceutical science, Sinology and the rule of law. The 2020 Tang Prize in Biopharmaceutical Science is jointly awarded to Drs. Charles Dinarello, Marc Feldmann and Tadamitsu Kishimoto, “for the development of cytokine-targeting biological therapies for treatment of inflammatory diseases” that brought a ray of hope to hundreds of thousands of patients debilitated by this degenerative condition.
The Tang Prize Foundation, Experimental Biology (EB) and National Cheng Kung University will co-host the 2020 Tang Prize Masters’ Forum on biopharmaceutical science, taking place from 9a.m. to 11:20 am. (GMT+8) Taiwan time, on September 22. This forum features three 2020 laureates speaking on the topic, “Targeting the Hyperactive Immune System, from Autoimmune Disease to Cytokine Storms,” keeping us abreast of the latest development in biomedical science in the age of coronavirus. In addition, 2014 Tang Prize and 2018 Nobel Prize winners Dr. James P. Allison and Dr. Tasuku Honjo will also take part in the discussion, brainstorming with us to spot all the opportunities for the development of biopharmaceutical research that could be opened up because of this health crisis.
If you are interesed, please sign in: https://forms.gle/
![]() |
Many of the severe cases of COVID-19 result from the excessive reaction of the patients’ immune system, causing "cytokine storms" to wreak havoc in their bodies and lead to multiple organ failures. The world races to find new drugs and vaccines to eradicate the virus, but this may take considerable amount of time. There is an existing subset of drugs (biologics) used to temper inflammatory reactions caused by immune system overdrive. Many of these are undergoing trials related to cytokine storms. How were these drugs discovered, and how can their impact be even greater today? The three laureates of the 2020 Tang Prize will talk about interluekin-1, interleukin-6, and TNF, the three most critical cytokines not only in cytokine storms, but also in autoimmune and autoinflammatory diseases that affect the lives of a large number of people. |
Taiwan Time: |
Tuesday, September 22, 2020 09:00-11:20 |
Venue: |
Cheng-Shing Hall, National Cheng Kung University, Taiwan |
09:00-09:15 |
Welcome Remarks Shu Chien / President, Tang Prize Selection Committee William B. Coleman / Representative, Experimental Biology Huey-Jen Su / President, National Cheng Kung University |
09:15-10:15 |
2020 Laureates’ Presentations |
10:15-10:45 |
Panel Discussion |
10:45-11:15 |
Q & A (Questions accepted online) |
11:15-11:20 |
Closing Remarks |
Moderators | |||
![]() |
|
||
![]() |
|
||
Panelists / Past Laureates | |||
![]() |
|
||
![]() |
|
||
![]() |
|
||
![]() |
|
||
![]() |
|